Update to the study protocol for a randomized controlled trial comparing mindfulness-based cognitive therapy with maintenance anti-depressant treatment depressive relapse/recurrence: the PREVENT trial. by Kuyken, W et al.
TRIALS
Kuyken et al. Trials 2014, 15:217
http://www.trialsjournal.com/content/15/1/217UPDATE Open AccessUpdate to the study protocol for a randomized
controlled trial comparing mindfulness-based
cognitive therapy with maintenance
anti-depressant treatment depressive relapse/
recurrence: the PREVENT trial
Willem Kuyken1*, Sarah Byford2, Richard Byng3, Tim Dalgleish4, Glyn Lewis5, Rod Taylor3, Edward R Watkins1,
Rachel Hayes1, Paul Lanham6, David Kessler5, Nicola Morant7 and Alison Evans1Abstract
Background: Depression is a common and distressing mental health problem that is responsible for significant
individual disability and cost to society. Medication and psychological therapies are effective for treating depression
and maintenance anti-depressants (m-ADM) can prevent relapse. However, individuals with depression often express
a wish for psychological help that can help them recover from depression in the long-term. A recently developed
treatment, mindfulness-based cognitive therapy (MBCT), shows potential as a brief group program for people with
recurring depression.
This trial asks the policy research question; is MBCT with support to taper/discontinue antidepressant medication
(MBCT-TS) superior to m-ADM in terms of: a primary outcome of preventing depressive relapse/recurrence over
24 months; and secondary outcomes of (a) depression free days, (b) residual depressive symptoms, (c) antidepressant
medication (ADM) usage, (d) psychiatric and medical co-morbidity, (e) quality of life, and (f) cost effectiveness? An
explanatory research question also asks whether an increase in mindfulness skills is the key mechanism of change.
The design is a single-blind, parallel randomized controlled trial examining MBCT-TS versus m-ADM with an embedded
process study. To answer the main policy research question the proposed trial compares MBCT-TS with m-ADM for
patients with recurrent depression. Four hundred and twenty patients with recurrent major depressive disorder in full
or partial remission will be recruited through primary care.
Results: Depressive relapse/recurrence over two years is the primary outcome variable. Analyses will be conducted
following CONSORT standards and overseen by the trial’s Data Monitoring and Safety Committee. Initial analyses will
be conducted on an intention-to-treat basis, with subsequent analyses being per protocol. The explanatory question
will be addressed in two mutually informative ways: quantitative measurement of potential mediating variables
pre- and post-treatment and a qualitative study of service users’ views and experiences.
Conclusions: If the results of our exploratory trial are extended to this definitive trial, MBCT-TS will be established as an
alternative approach to maintenance antidepressants for people with a history of recurrent depression. The process
studies will provide evidence about the effective components which can be used to improve MBCT and inform theory
as well as other therapeutic approaches.
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This update relates to the study protocol for a rando-
mized controlled trial comparing mindfulness-based
cognitive therapy with maintenance anti-depressant treat-
ment in the prevention of depressive relapse/recurrence:
the PREVENT trial. This update should be read in con-
junction with the original protocol publication [1].
Reworded research question
To ensure that readers clearly understand that this trial
is not a direct comparison between antidepressant medi-
cation (ADM) and Mindfulness-based cognitive therapy
(MBCT), but ADM versus MBCT plus tapering support
(MBCT-TS), the primary research question has been
changed following the recommendation made by the
Trial Steering Committee at their meeting on 24 June
2013. The revised primary research question now reads
as follows: ‘Is MBCT with support to taper/discontinue
antidepressant medication (MBCT-TS) superior to main-
tenance antidepressant medication (m-ADM) in prevent-
ing depression over 24 months?’ In addition, the acronym
MBCT-TS will be used to emphasise this aspect of the
intervention.
Subgroup analysis high versus low childhood adversity
The Trial Management Group met on 8 May 2013 and
discussed the early dissemination via personal communi-
cation of Williams et al. (subsequently published [2])
comparison of MBCT, cognitive psychological educa-
tion and treatment-as-usual. This study suggested that
MBCT compared with the other two conditions con-
fers a significant protection against relapse for partici-
pants with increased vulnerability due to a history of
childhood trauma. It was agreed at this meeting that
an additional subgroup analysis should be added to
our statistical analysis plan to examine the potential
difference in treatment outcome as related to child-
hood adversity. This will be undertaken by examining
the interaction of childhood abuse with treatment al-
location on the primary outcome at 24 months. The
statistical analysis plan was updated accordingly on 15
May 2013.
Ethical approval and trial governance
We have received multicenter ethical approval (South
West Exeter Research Ethics Committee, 09/H0206/43)
and local research governance approval for all sites (NHS
Devon covering Exeter and Mid-and North-Devon,PCT0739; NHS Bristol, covering Bristol site, 2010-004,
NHS Plymouth and NHS Torbay, PLY-TOR001 covering
South Devon site). The study personnel, management
group, and independent Trial Steering Committee will
ensure that the study is conducted within appropriate
NHS and professional ethical guidelines, ensuring that
Good Clinical Practice guidelines are observed at all times.
This trial has been approved by the Medicines and
Healthcare products Regulatory Agency (EudraCT num-
ber 2009-012428-10). All participants gave full informed
consent.
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